[Pirfenidone inhibits bladder cancer xenograft growth in mice by regulating regulatory T cells]. [PDF]
Zhang H +5 more
europepmc +1 more source
Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis. [PDF]
Yin G +5 more
europepmc +1 more source
[Apelin promotes proliferation, migration, and angiogenesis in bladder cancer by activating the FGF2/FGFR1 pathway]. [PDF]
Su W +6 more
europepmc +1 more source
[Dihydroartemisinin inhibits the progression of oral squamous cell carcinoma]. [PDF]
Shan T +5 more
europepmc +1 more source
O-GlcNAcylated YTHDF2 promotes bladder cancer progression by regulating the tumor suppressor gene <i>PER1</i> via m<sup>6</sup>A modification. [PDF]
Wang L +5 more
europepmc +1 more source
[Research progress in the role of STMN1 in tumor]. [PDF]
Ma X, Li M, Chen, Mei H, Rong Z.
europepmc +1 more source
[Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. [PDF]
Feng Y +9 more
europepmc +1 more source
在世界范围内,膀胱癌诊出率居于恶性肿瘤中的第九位,2022年在全球范围内约有61万个新发病例和22万个死亡病例[1]。以手术切除为主,放化疗和免疫治疗相结合的策略在膀胱癌的治疗上取得了很大成功,但晚期膀胱癌患者的预后仍然较差[2]。因此,我们应该积极寻找和评估新的用于诊断及预后监测的生物标志物。
李婷淼, 薛菲, 岳斯琦, 何成彦
doaj
[Analysis of setup errors and their correlation with clinical factors in image-guided radiotherapy for prostate cancer using different immobilization devices]. [PDF]
Guo X +5 more
europepmc +1 more source

